{"id":"129xe","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL4594411","moleculeType":"Small molecule","molecularWeight":"128.90"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Xenon-129 is polarized to enhance its magnetic resonance signal, allowing it to be inhaled and imaged to assess regional lung ventilation, perfusion, and gas exchange dynamics. This enables non-invasive evaluation of pulmonary function and detection of ventilation defects in various respiratory conditions.","oneSentence":"Xenon-129 is a hyperpolarized noble gas used as a contrast agent for magnetic resonance imaging to visualize lung ventilation and gas exchange.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:19:17.773Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Pulmonary ventilation imaging in patients with suspected or known lung disease"},{"name":"Assessment of regional lung function and ventilation defects"}]},"trialDetails":[{"nctId":"NCT02740868","phase":"PHASE2","title":"Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease","status":"RECRUITING","sponsor":"The Hospital for Sick Children","startDate":"2015-08","conditions":"Cystic Fibrosis, Asthma","enrollment":30},{"nctId":"NCT06104228","phase":"PHASE2","title":"129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2024-08-12","conditions":"Pulmonary Arterial Hypertension, Idiopathic Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder)","enrollment":20},{"nctId":"NCT04778046","phase":"PHASE2","title":"Pulmonary Hypertension SOLAR","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2023-11-08","conditions":"Interstitial Lung Disease, COPD, Pulmonary Arterial Hypertension","enrollment":30},{"nctId":"NCT05241275","phase":"PHASE2","title":"Xenon MRI and Progressive ILD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2022-07-19","conditions":"Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis","enrollment":60},{"nctId":"NCT06351345","phase":"PHASE2","title":"129 Xenon Imaging in Patients Treated With Sotatercept","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2025-10-27","conditions":"Pulmonary Hypertension, Pulmonary Arterial Hypertension","enrollment":14},{"nctId":"NCT06909201","phase":"PHASE1","title":"Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity","status":"SUSPENDED","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-10-16","conditions":"Lung Cancer","enrollment":70},{"nctId":"NCT06012500","phase":"PHASE1, PHASE2","title":"Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2022-04-14","conditions":"ILD","enrollment":78},{"nctId":"NCT04035629","phase":"PHASE1","title":"129Xe MRI in Pediatric Population With BPD","status":"WITHDRAWN","sponsor":"Xemed LLC","startDate":"2026-08-01","conditions":"Bronchopulmonary Dysplasia","enrollment":""},{"nctId":"NCT04855305","phase":"PHASE2","title":"Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2021-11-12","conditions":"Interstitial Lung Diseases","enrollment":46},{"nctId":"NCT06038630","phase":"PHASE2","title":"129Xe MRI Cardiopulmonary","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2024-01-12","conditions":"Interstitial Lung Disease, Chronic Thromboembolic Pulmonary Hypertension, Acute Pulmonary Embolism","enrollment":125},{"nctId":"NCT04467957","phase":"PHASE4","title":"Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-11-15","conditions":"Cystic Fibrosis","enrollment":26},{"nctId":"NCT01280994","phase":"PHASE2","title":"Hyperpolarized 129Xe MRI for Imaging Pulmonary Function","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2011-01","conditions":"Interstitial Lung Disease","enrollment":445},{"nctId":"NCT04995562","phase":"PHASE4","title":"Use of Hyperpolarized 129Xe MR Lung Imaging in Infants","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-05-06","conditions":"Lungs; Developmental Disorder","enrollment":12},{"nctId":"NCT04991389","phase":"PHASE4","title":"Improving Outcomes in Pediatric Obstructive Sleep Apnea With Computational Fluid Dynamics","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2019-08-15","conditions":"Obstructive Sleep Apnea","enrollment":120},{"nctId":"NCT04259970","phase":"PHASE4","title":"Hyperpolarized Imaging for New Treatments","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-01-13","conditions":"Cystic Fibrosis","enrollment":64},{"nctId":"NCT02220426","phase":"PHASE1","title":"Hyperpolarized Xenon-129 Magnetic Resonance Imaging and Spectroscopy of Brown Fat: Healthy Adult Volunteer Pilot Study","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2015-09-01","conditions":"Obesity","enrollment":17},{"nctId":"NCT04991454","phase":"PHASE2","title":"Xenon MRI Pulm Hypertension","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2021-09-01","conditions":"Pulmonary Hypertension, Pulmonary Arterial Hypertension","enrollment":60},{"nctId":"NCT07192016","phase":"PHASE4","title":"129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation","status":"NOT_YET_RECRUITING","sponsor":"Western University, Canada","startDate":"2026-03","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":60},{"nctId":"NCT02316379","phase":"PHASE1, PHASE2","title":"Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2015-02","conditions":"Respiratory Disorders","enrollment":100},{"nctId":"NCT05550662","phase":"PHASE2","title":"HP 129Xe MRI for Evaluation of CLAD in Lung Transplant Recipients","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2024-02-07","conditions":"Lung Transplant Rejection","enrollment":6},{"nctId":"NCT04651777","phase":"PHASE3","title":"Evaluation of Triple Therapy Using Magnetic Resonance Imaging in Asthma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr. Grace Parraga","startDate":"2022-08-08","conditions":"Asthma","enrollment":31},{"nctId":"NCT07143747","phase":"","title":"PAXT: Pulmonary Imaging of Mild Asthma Using 129Xe MRI and Tc-99-Labeled-Carbon-Imaging (Tc99CImaging)","status":"NOT_YET_RECRUITING","sponsor":"Dr. Grace Parraga","startDate":"2025-09","conditions":"Mild Asthma","enrollment":40},{"nctId":"NCT04616313","phase":"","title":"Novel Pulmonary Imaging of Lung Structure and Function in E-cigarette Smokers","status":"RECRUITING","sponsor":"Western University, Canada","startDate":"2023-01-17","conditions":"E Cigarette Use","enrollment":150},{"nctId":"NCT04584671","phase":"","title":"Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Western University, Canada","startDate":"2021-01-01","conditions":"Covid19","enrollment":100},{"nctId":"NCT03431129","phase":"","title":"Hyperpolarized 129Xe Magnetic Resonance Imaging for Evaluation of Radiation-Induced Lung Injury in Subjects Undergoing Thoracic Irradiation","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2018-09-01","conditions":"Radiation Induced Lung Injury (RILI)","enrollment":1},{"nctId":"NCT05014516","phase":"","title":"Lung Structure-Function In SurVivors of Mild and SEvere COVID-19 Infection: 129Xe MRI","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2021-08-05","conditions":"COVID-19 Respiratory Infection","enrollment":9},{"nctId":"NCT02912637","phase":"","title":"Hyperpolarized Xenon Imaging in Patients With Cystic Fibrosis","status":"WITHDRAWN","sponsor":"Papworth Hospital NHS Foundation Trust","startDate":"2016-10","conditions":"Cystic Fibrosis","enrollment":""},{"nctId":"NCT05138250","phase":"PHASE3","title":"A Pilot Study of the Use of 129Xe and 1H MRI to Measure the Modulation of Eosinophil-Related Inflammation by Mepolizumab In COPD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2022-05-26","conditions":"COPD","enrollment":32},{"nctId":"NCT04624490","phase":"PHASE1","title":"Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease","status":"RECRUITING","sponsor":"Mario Castro, MD, MPH","startDate":"2020-11-02","conditions":"Asthma, COPD, Interstitial Lung Disease","enrollment":260},{"nctId":"NCT04659707","phase":"PHASE1","title":"Hyperpolarized 129Xe MRI of Survivors of COVID-19","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2021-02-22","conditions":"Covid19","enrollment":20},{"nctId":"NCT05204355","phase":"","title":"MRI for Screening and Monitoring Scleroderma ILD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2022-05-01","conditions":"Scleroderma","enrollment":25},{"nctId":"NCT05766384","phase":"","title":"Hyperpolarized 129Xe MRI Lung Health Cohort","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2023-11-30","conditions":"Healthy","enrollment":260},{"nctId":"NCT05339386","phase":"","title":"Developing Hyperpolarized 129Xe MRI Biomarkers for Evaluation of Pulmonary Arterial Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2022-08-29","conditions":"Pulmonary Arterial Hypertension","enrollment":10},{"nctId":"NCT06406777","phase":"PHASE1, PHASE2","title":"Chronic Lung Allograft Dysfunction MRI Study","status":"RECRUITING","sponsor":"Sean Fain","startDate":"2025-03-20","conditions":"Chronic Lung Allograft Dysfunction Lung MRI (CLAD)","enrollment":100},{"nctId":"NCT04793867","phase":"","title":"Regional Phenotyping of CF and Non-CF Bronchiectasis","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2021-02-08","conditions":"Cystic Fibrosis, Non-CF Bronchiectasis","enrollment":100},{"nctId":"NCT05517655","phase":"PHASE4","title":"BEGIN Novel ImagiNG Biomarkers","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2022-05-01","conditions":"Cystic Fibrosis","enrollment":44},{"nctId":"NCT02848560","phase":"","title":"Monitoring Response to Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2016-03","conditions":"Cystic Fibrosis","enrollment":38},{"nctId":"NCT04761393","phase":"","title":"Characterizing Matrix Metalloproteinase-12 (MMP12) in Sputum","status":"RECRUITING","sponsor":"McMaster University","startDate":"2022-11-29","conditions":"Emphysema","enrollment":45},{"nctId":"NCT02638519","phase":"EARLY_PHASE1","title":"HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease","status":"TERMINATED","sponsor":"Thunder Bay Regional Health Research Institute","startDate":"2016-06-27","conditions":"Alzheimer Disease","enrollment":51},{"nctId":"NCT02748798","phase":"EARLY_PHASE1","title":"Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders","status":"TERMINATED","sponsor":"Thunder Bay Regional Health Research Institute","startDate":"2020-11-10","conditions":"Lung Transplant, Lung Resection, Lung Cancer","enrollment":10},{"nctId":"NCT02484885","phase":"NA","title":"Xenon-129 Magnetic Resonance Imaging of Healthy Subjects: Hardware and Software Development and Reproducibility","status":"RECRUITING","sponsor":"Western University, Canada","startDate":"2011-08","conditions":"Healthy Volunteers","enrollment":50},{"nctId":"NCT02279329","phase":"NA","title":"Longitudinal Study of Helium-3 and Xenon-129 Magnetic Resonance Imaging","status":"RECRUITING","sponsor":"Dr. Grace Parraga","startDate":"2009-05","conditions":"COPD, Bronchiectasis","enrollment":200},{"nctId":"NCT02723500","phase":"NA","title":"129 Xenon MRI in Chronic Lung Disease","status":"RECRUITING","sponsor":"Western University, Canada","startDate":"2011-08","conditions":"Lung Disease","enrollment":100},{"nctId":"NCT03455686","phase":"NA","title":"Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease","status":"RECRUITING","sponsor":"McMaster University","startDate":"2018-04-19","conditions":"Asthma, Chronic Obstructive Pulmonary Disease, Bronchiectasis","enrollment":60},{"nctId":"NCT04828135","phase":"PHASE2","title":"Dual MRI for Cardiopulmonary COVID-19 Long Haulers","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2021-05-26","conditions":"Covid19","enrollment":18},{"nctId":"NCT06122922","phase":"PHASE2","title":"Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN)","status":"WITHDRAWN","sponsor":"Bastiaan Driehuys","startDate":"2024-03-15","conditions":"Pulmonary Artery Hypertension","enrollment":""},{"nctId":"NCT04191174","phase":"","title":"Ventilation Heterogeneity Prior to Lung Resection","status":"UNKNOWN","sponsor":"McMaster University","startDate":"2020-01-06","conditions":"Lung Cancer","enrollment":115},{"nctId":"NCT04858191","phase":"","title":"Utilizing Hyperpolarized 129Xe Magnetic Resonance Imaging in Children With Primary Ciliary Dyskinesia","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2021-09-01","conditions":"Primary Ciliary Dyskinesia","enrollment":16},{"nctId":"NCT03367312","phase":"PHASE2","title":"Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2018-03-29","conditions":"Pulmonary Vascular Disease","enrollment":11},{"nctId":"NCT03632369","phase":"","title":"Hyperpolarized Noble Gas MRI Detection of Radiation-Induced Lung Injury","status":"WITHDRAWN","sponsor":"Thunder Bay Regional Health Research Institute","startDate":"2016-12","conditions":"Radiation Induced Lung Injury, Non Small Cell Lung Cancer","enrollment":""},{"nctId":"NCT02478255","phase":"PHASE2","title":"Longitudinal MR Imaging of Pulmonary Function in Patients Receiving Thoracic Radiation Treatment","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2016-03-21","conditions":"Radiation Injury","enrollment":25},{"nctId":"NCT02976935","phase":"","title":"Functional MR Lung Imaging Using Hyperpolarised 129Xe","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2014-02","conditions":"COPD, IPF","enrollment":53},{"nctId":"NCT02736422","phase":"PHASE1","title":"Assessment of New Magnetic Resonance Imaging (MRI) Pulse Sequences for Imaging Hyperpolarised Xenon in Lung, Heart and Brain in Volunteers","status":"COMPLETED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2011-07","conditions":"Healthy Volunteers","enrollment":40},{"nctId":"NCT04677426","phase":"PHASE2","title":"129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study","status":"WITHDRAWN","sponsor":"University of Kansas Medical Center","startDate":"2022-05-01","conditions":"Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis","enrollment":""},{"nctId":"NCT03417687","phase":"PHASE3","title":"Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Resection","status":"COMPLETED","sponsor":"Polarean, Inc.","startDate":"2018-08-17","conditions":"Pulmonary Surgical Procedures","enrollment":38},{"nctId":"NCT03078192","phase":"PHASE2","title":"Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2017-05-03","conditions":"Pulmonary Vascular Disease","enrollment":62},{"nctId":"NCT02478268","phase":"PHASE1","title":"Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2015-05","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":64},{"nctId":"NCT03482960","phase":"EARLY_PHASE1","title":"Comparison of 129Xe MRI With 19F MRI in CF Lung Disease","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2018-05-29","conditions":"Cystic Fibrosis","enrollment":11},{"nctId":"NCT03324607","phase":"PHASE2, PHASE3","title":"Effects of Bevespi on Ventilation and Gas Exchange Abnormalities in COPD Assessed by 129Xe MRI","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2018-04-20","conditions":"COPD","enrollment":20},{"nctId":"NCT03418090","phase":"PHASE3","title":"Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Transplant","status":"COMPLETED","sponsor":"Polarean, Inc.","startDate":"2018-08-17","conditions":"Pulmonary Surgical Procedures","enrollment":48},{"nctId":"NCT04029636","phase":"","title":"Hyperpolarized 129Xe MRI for the Assessment of BOS With Late Onset LONIPC","status":"UNKNOWN","sponsor":"Hamilton Health Sciences Corporation","startDate":"2019-08","conditions":"Bronchiolitis Obliterans","enrollment":45},{"nctId":"NCT01697332","phase":"PHASE1, PHASE2","title":"Functional Applications of Hyperpolarized 129Xe MRI","status":"TERMINATED","sponsor":"Brigham and Women's Hospital","startDate":"2013-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":1}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":946,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"129Xe","genericName":"129Xe","companyName":"Children's Hospital Medical Center, Cincinnati","companyId":"children-s-hospital-medical-center-cincinnati","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Xenon-129 is a hyperpolarized noble gas used as a contrast agent for magnetic resonance imaging to visualize lung ventilation and gas exchange. Used for Pulmonary ventilation and gas exchange imaging in patients with chronic obstructive pulmonary disease, Assessment of regional lung function in asthma and other respiratory disorders.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}